Analysis of the meal-dependent intragastric performance of a gastric-retentive tablet assessed by magnetic resonance imaging

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 7, 2003, Pages 713-720

  Steingoetter, A ^a,c   Kunz, P ^b   Weishaupt, D ^c   Mader K ^b   Lengsfeld, H ^b   Thumshirn, M ^c   Boesiger, P ^a   Fried, M ^c   Schwizer, W ^c  

^a ETH ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL AGENT; IRON OXIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG HALF LIFE; DRUG MONITORING; DRUG SCREENING; FOOD COMPOSITION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; SITTING; TABLET FORMULATION;

ADULT; FOOD; GASTRIC EMPTYING; HALF-LIFE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SENSITIVITY AND SPECIFICITY; STOMACH; TABLETS; TIME FACTORS;

EID: 0142027675     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01655.x     Document Type: Article

References (25)

1. Davis SS. Delivery systems for biopharmaceuticals. J Pharm Pharmacol 1992; 44(Suppl. 1): 186-90.
2. Wilding IR, Davis SS, O'Hagan DT. Optimizing gastrointestinal delivery of drugs. Baillieres Clin Gastroenterol 1994; 8(2): 255-70.
3. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Controlled Release 2000; 63(3): 235-59.
4. Sangalli ME, Maroni A, Zema L, Busetti C. Giordano F, Gazzaniga A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Controlled Release 2001; 73(1): 103-10.
5. Fell JT. Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract. J Anat 1996; 189(3): 517-9.
6. Goddard AF. Review article: factors influencing antibiotic transfer across the gastric mucosa. Aliment Pharmacol Ther 1998; 12(12): 1175-84.
7. Wikberg M, Ulmius J, Ragnarsson G. Review article: targeted drug delivery in treatment of intestinal diseases. Aliment Pharmacol Ther 1997; 11(Suppl. 3): 109-15.
8. Bruno MJ, Haverkort EB, Tytgat GN, van Leeuwen DJ. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol 1995; 90(9): 1383-93.
9. Davis SS, Hardy JG, Newman SP, Wilding IR. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur J Nucl Med 1992; 19(11): 971-86.
10. Wilson CG. In-vivo monitoring of dosage forms. J Pharm Pharmacol 1998: 50(4): 383-6.
11. Kedzierewicz F, Thouvenot P, Lemut J. Etienne A, Huffman M, Maincent P. Evaluation of peroral silicone dosage forms in humans by gamma-scintlgraphy. J Controlled Release 1999; 58(2): 195-205.
12. Wilding IR. Coupe AJ, Davis SS. The role of gamma-scintigraphy in oral drug delivery. Adv Drug Deliv Rev 2001; 46(1-3): 103-24.
13. Christmann V, Rosenberg J, Seega J, Lehr CM. Simultaneous in vivo visualization and localization of solid oral dosage forms in the rat gastrointestinal tract by magnetic resonance imaging (MRI). Pharm Res 1997; 14(8): 1066-72.
14. Fahie BJ, Nangia A, Chopra SK, Fyfe CA, Grondey H, Blazek A. Use of NMR imaging in the optimization of a compression-coated regulated release system. J Controlled Release 1998; 51(2-3): 179-84.
15. Faas H, Schwizer W, Feinle C, et al. Monitoring the intragastric distribution of a colloidal drug carrier model by magnetic resonance imaging. Pharm Res 2001; 18(4): 460-6.
16. Steingoetter A, Weishaupt D, Kunz P, et al. Evaluation of superparamagnetic particles as MRI marker for tablet formulations. Proc Int Soc Magn Reson Med 2002; 10: 2579.
17. Muller RN, Gillis P, Moiny F, Roch A. Transverse relaxivity of particulate MRI contrast media: from theories to experiments. Magn Reson Med 1991; 22(2): 178-82; discussion 195-6.
18. Kennan RP, Zhong J, Gore JC. On the relative importance of paramagnetic relaxation and diffusion-mediated susceptibility losses in tissues. Magn Reson Med 1991; 22(2): 197-203: discussion 213-5.
19. Bach-Gansmo T. Ferrimagnetic susceptibility contrast agents. Acta Radiol Suppl 1993; 387: 1-30.
20. Brooks RA. T(2)-shortening by strongly magnetized spheres: a chemical exchange model. Magn Reson Med 2002; 47(2): 388-91.
21. Gillis P, Moiny F, Brooks RA. On T(2)-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med 2002; 47(2): 257-63.
22. Kunz P, Feinle C, Schwizer W, Fried M, Boesiger P. Assessment of gastric motor function during the emptying of solid and liquid meals in humans by MRI. J Magn Reson Imaging 1999; 9(1): 75-80.
23. Marciani L, Young P, Wright J, et al. Antral motility measurements by magnetic resonance imaging. Neurogastroenterol Motil 2001; 13(5): 511-8.
24. Maughan RJ, Leiper JB. Methods for the assessment of gastric emptying in humans: an overview. Diabet Med 1996: 13(9 Suppl. 5): S6-10.
25. Verbeeck RK. Blood microdialysis in pharmacokinetic and drug metabolism studies. Adv Drug Deliv Rev 2000; 45(2-3): 217-28.